Neurocrine Biosciences NBIX
NASDAQ NBIX
$155.40 -0.14 (-0.09%)
At close: Aug 20, 2026 · 11:01 AM UTC

Neurocrine Biosciences (NBIX) Sales of Property, Plant and Equipment (2010 - 2019)

Neurocrine Biosciences (NBIX) Sales of Property, Plant and Equipment (2010 - 2019) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Haleon 43.81 Bn 42.84 Bn - -
2 Teva Pharmaceutical Industries 43.29 Bn 39.63 Bn 2.15 Bn -
3 Zoetis 31.59 Bn 29.91 Bn 1.05 Bn 1.00 Mn
4 Takeda Pharmaceutical 28.67 Bn 22.88 Bn 5.10 Bn 6.88 Mn
5 United Therapeutics 22.24 Bn 19.58 Bn 683.80 Mn -
6 Viatris 18.79 Bn 17.91 Bn 1.46 Bn 8.20 Mn
7 Neurocrine Biosciences 15.71 Bn 15.32 Bn 935.80 Mn -
8 Elanco Animal Health 12.09 Bn 11.56 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.11 Bn 9.95 Bn - -
10 Alkermes 8.19 Bn 7.53 Bn 397.90 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2019 4,000.00
Sep 30, 2019 4,000.00
Mar 31, 2019 4,000.00
Mar 31, 2019 4,000.00
Dec 31, 2018 4,000.00
Dec 31, 2018 4,000.00
Jun 30, 2018 12,000.00
Jun 30, 2018 12,000.00
Mar 31, 2018 18,000.00
Mar 31, 2018 18,000.00
Sep 30, 2017 7,000.00
Sep 30, 2017 7,000.00
Jun 30, 2016 10,000.00
Jun 30, 2016 10,000.00
Mar 31, 2016 3,000.00
Mar 31, 2016 3,000.00
Mar 31, 2015 9,000.00
Mar 31, 2015 9,000.00
Jun 30, 2014 5,000.00
Jun 30, 2014 5,000.00